Oseltamivir (Tamiflu) Induced Depressive Episode in a Female Adolescent

Oseltamivir-Induced Mania in a Patient With H1N1

(2010) Lily N.L. Ho et al.   AMERICAN JOURNAL OF PSYCHIATRY

Oseltamivir and Abnormal Behaviors

(2009) Takashi Yorifuji et al.   EPIDEMIOLOGY

In vitro pharmacological selectivity profile of oseltamivir prodrug (Tamiflu®) and active metabolite

(2009) Lothar Lindemann et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Incidence of neuropsychiatric adverse events in influenza patients treated with oseltamivir or no antiviral treatment

(2009) J. R. Smith et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Limited Brain Distribution of [3R,4R,5S]-4-Acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate Phosphate (Ro 64-0802), a Pharmacologically Active Form of Oseltamivir, by Active Efflux across the Blood-Brain Barrier Mediated by Organic Anion Transporter 3 (Oat3/Slc22a8) and Multidrug Resistance-Associated Protein 4 (Mrp4/Abcc4)

(2008) A. Ose et al.   DRUG METABOLISM AND DISPOSITION

Assessment of Neuropsychiatric Adverse Events in Influenza Patients Treated with Oseltamivir

(2008) Stephen Toovey et al.   DRUG SAFETY

Oseltamivir (Tamiflu®) increases dopamine levels in the rat medial prefrontal cortex

(2008) Tatsuki Yoshino et al.   NEUROSCIENCE LETTERS